# Effectiveness of MyCancerGene to Optimize Genetic Testing Outcomes

> **NCT04774445** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Abramson Cancer Center at Penn Medicine** · enrollment: 400 (estimated)

## Conditions studied

- Cancer
- Genetic Predisposition

## Interventions

- **BEHAVIORAL:** MyCancerGene

## Key facts

- **NCT ID:** NCT04774445
- **Lead sponsor:** Abramson Cancer Center at Penn Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-05-03
- **Primary completion:** 2025-04-30
- **Final completion:** 2026-04-01
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2025-02-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04774445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04774445, "Effectiveness of MyCancerGene to Optimize Genetic Testing Outcomes". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04774445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*